
Nanotechnology-Based Innovations in Chronic Obstructive Pulmonary Disease (COPD) Treatment and Management
- 1st Edition - February 1, 2026
- Editors: Harish Dureja, Ronan MacLoughlin, John I. Disouza, Muralikrishnan Dhanasekaran, Kamal Dua, Lokesh Nagar
- Language: English
- Paperback ISBN:9 7 8 - 0 - 4 4 3 - 4 3 9 4 6 - 9
- eBook ISBN:9 7 8 - 0 - 4 4 3 - 4 3 9 4 7 - 6
Nanotechnology-Based Innovations in Chronic Obstructive Pulmonary Disease (COPD) Treatment and Management explores innovative drug delivery systems utilizing nanotechnology to rev… Read more
Purchase options

- Highlights cutting-edge nanotechnologies transforming COPD treatment and management for improved patient outcomes
- Discusses future directions and challenges in nanotechnology applications for COPD management
- Serves as a valuable resource for researchers, clinicians, and students in respiratory health fields
- Offers comprehensive coverage of innovative drug delivery systems for effective COPD diagnosis and therapy
- Integrates multidisciplinary insights from experts in pharmaceutical sciences, respiratory health, and bioinformatics
2. Introduction to COPD
3. Epidemiology and Pathophysiology of COPD
4. Immunology and Biomarkers of COPD
5. Nanotechnology-based Diagnosis of COPD
6. Polymeric nanoparticles for the Management of COPD
7. Solid lipid nanoparticles for the Management of COPD
8. Metal and metal oxide Nanoparticles for the Management of COPD
9. Nanomicelles for the Management of COPD
10. Liposomes for the Management of COPD
11. Nanoemulsions for the Management of COPD
12. Nanosuspensions for the Management of COPD
13. Dendrimers for the Management of COPD
14. Carbon nanotubes for the Management of COPD
15. Nanofibers for the Management of COPD
16. Quantum dots for the Management of COPD
17. Theranostic nanoparticles for the Management of COPD
18. Nano-immunotherapy for the Management of COPD
19. Green nanotechnology for the Management of COPD
20. Clinical trials of drug delivery systems for the Management of COPD
21. Challenges associated with nanotechnology and Future Directions in the Management of COPD
22. Bibliography
23. Glossary
- Edition: 1
- Published: February 1, 2026
- Language: English
HD
Harish Dureja
RM
Ronan MacLoughlin
JD
John I. Disouza
MD
Muralikrishnan Dhanasekaran
KD
Kamal Dua
Kamal Dua is an Associate Professor in the Discipline of Pharmacy at the University of Technology Sydney (UTS). Dr Dua has been recognised and named as one of Australia’s Top 250 researchers in 2025 and 2024 in Research Magazine by “The Australian” in the research discipline of Health and Medical sciences, and #1/research leader in the area of Pharmacology and Pharmacy (2025) and Toxicology (2024) respectively. With over 17 years of research experience, he has specialised in drug delivery targeting inflammatory diseases. Additionally, Dr Dua also leads drug delivery research at the Woolcock Institute of Medical Research. In this role, he focuses on advancing targets identified in research projects to develop innovative formulations, taking the first steps toward clinical translation. Dr Dua’s research encompasses two complementary areas: drug delivery and immunology. His work explores how these disciplines can mutually benefit, contributing to the goal of promoting longer and healthier lives for the community. His commitment to synergy is reflected in his extensive publication record in reputable journals. Dr Dua’s research interests are centered on harnessing the pharmaceutical potential of modulating critical regulators, such as interleukins and microRNAs. He also specialises in developing new and effective drug delivery formulations for managing inflammation in chronic airway diseases and cancer.
LN
Lokesh Nagar
Lokesh holds a Bachelor's Degree in Pharmacy (“Maharshi Dayanand University, Rohtak, India”) and a Master's degree in Industrial Pharmacy (Maharshi Dayanand University, Rohtak, India). He is currently pursuing a PhD in Pharmaceutical Sciences at the Maharshi Dayanand University, Rohtak, India, with a thesis on the Formulation, Optimization and Characterization of Nanoemulsion-based Drug Delivery for the treatment of COPD. Lokesh has an experience as an academic researcher, particularly in the setup and evaluation of nano formulations. Lokesh's current expertise and research interest cover the in vitro advanced drug delivery of pharmaceuticals for the treatment of COPD and pulmonary fibrosis.